Veradermics, Inc. (MANE)
106.14
-1.71
(-1.59%)
USD |
NYSE |
May 08, 16:00
105.84
-0.30
(-0.28%)
Pre-Market: 20:00
Veradermics Shareholders Equity (Quarterly) : 145.31M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Organon & Co. | 903.00M |
| Merck & Co., Inc. | 45.88B |
| Bristol Myers Squibb Co. | 20.07B |
| Terns Pharmaceuticals, Inc. | 1.007B |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 154.47M |
| Total Liabilities (Quarterly) | 9.156M |
| Current Ratio | 16.29 |